From Name:
From Email:
To Name:
To Email:

Optional Message:


Promising Canadian stroke drug receives large research grant

from The Globe and Mail

A Phase III trial involving a promising stroke drug will receive a $6.6 million injection from Brain Canada — yet another endorsement for a Canadian medication that takes aim at the country's third leading cause of death. The intravenous medication, called NA-1, is the $30 million, private venture of a company called NoNO. Its development, nearly 20 years in the making, is unusual: It is neither in bed with a large pharmaceutical company nor has it relied on the largesse of the public purse. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063